KNSA
Kiniksa Pharmaceuticals Ltd.
Company Overview
| Mkt Cap | $2.81B | Price | $37.01 |
| Volume | 481.67K | Change | -0.75% |
| P/E Ratio | -65.0 | Open | $37.43 |
| Revenue | $423.2M | Prev Close | $37.29 |
| Net Income | $-43.2M | 52W Range | $17.82 - $42.05 |
| Div Yield | N/A | Target | $50.75 |
| Overall | 44 | Value | 25 |
| Quality | 57 | Technical | 50 |
No chart data available
Stock Overview
Updated DailyKiniksa Pharmaceuticals Ltd. (KNSA) is a leading Healthcare company in the Biotechnology industry, currently trading at $37.01 with a market capitalization of $2.81 billion. The stock is positioned in the upper portion of its trading range, demonstrating average quality indicators with a MarketXLS quality score of 57.
Today's trading session shows KNSA with a volume of 482K shares. The stock opened up 0.38% from yesterday's close of $37.29. Current analyst estimates project earnings of $0.95 per share for this year, with next year targeting $1.23.
KNSA demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for KNSA include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 37.1%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:12 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KNSA | $37.01 | -0.8% | 481.67K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kiniksa Pharmaceuticals Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW